Background People who inject drugs (PWID) experience many health problems which result
in a heavy economic and public health burden. To tackle this issue, France opened two drug …

Background The effectiveness of drug consumption rooms (DCRs) for people who inject
drugs (PWID) has been demonstrated for HIV and hepatitis C virus risk practices, and …

Introduction The high prevalence of hepatitis C and the persistence of HIV and hepatitis C
virus (HCV) risk practices in people who inject drugs (PWID) in France underlines the need …

Background and aims Despite the availability of several drug consumption rooms (DCR) in
different European countries few epidemiological studies have evaluated their benefits. A …

People who use illicit drugs (PWUD) experience a wide range of drug-related harms. The
goal of harm reduction is to reduce these adverse effects of drug use, without necessarily …

Introduction The main harm reduction interventions for people who inject drugs (PWID) are
supervised injection facilities, needle and syringe programmes and opioid agonist treatment …

Drug consumption rooms (DCRs) are professionally supervised healthcare facilities where
drug users can use drugs in safer and more hygienic conditions. Since 1986, more than 90 …

Background Drug consumption rooms (DCRs) and supervised injecting facilities (SIFs)
provide a safe environment in which people who inject drugs (PWIDs) can inject under …

This article discusses the learning and politics involved in spreading Drug Consumption
Rooms (DCRs) globally. DCRs are health facilities, operating under a harm reduction …

Issue Drug consumption rooms (DCR) are in place for more than three decades in Europe
and have been proven to be effective as a public health response. However, their …